Table 2 Baseline characteristics of ALS patients and controls.

From: Genetic analysis of ALS cases in the isolated island population of Malta

 

ALS

(n = 24)

Controls

(n = 13)

Sex

 Male, % (n)

66.7 (16)

46.2 (6)

 Female, % (n)

33.3 (8)

53.8 (7)

Type

 Familial, % (n)

12.5 (3)

 Sporadic, % (n)

87.5 (21)

Age at onset

 Mean year ± SD (range)

59.3 ± 13.2 (27–80)

Age at recruitment

 Mean year ± SD (range)

63.5 ± 11.6 (30–82)

71.2 ± 10.9 (52–90)

ALSFRS-R score, mean ± SD (range)

25.6 ± 11.1 (11.5–44)

47.9 ± 0.3 (47–48)

Site of onset

 Spinal, % (n)

70.8 (17)

 Bulbar, % (n)

25 (6)

 Both, % (n)

4.2 (1)

 

Survival, mean years ± SD (range)

5.5 ± 5.1 (2-20)

Deceased, % (n)

62.5 (15)

Cognitive status

 Normal, % (n)

95.8 (23)

100 (13)

 Impaired, % (n)

4.2 (1)

0 (0)

Environmental risk factors

 Heavy smoking, % (n)

33.3 (8)

23.1 (3)

 Strenuous activity, % (n)

54.2 (13)

23.1 (3)

 Excessive alcohol consumption, % (n)

8.3 (2)

7.8 (1)

CK levels at recruitment, IU/La

 Mean in males ± SD (range)

311.2 ± 259.7 (15–863)

 Mean in females ± SD (range)

180.8 ± 117.5 (38–336)

  1. ALSFRS-R Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised, CK creatine kinase.
  2. aNormal CK range = 39–308 U/L (males), 26–192 U/L (females).